GSK president sells 40,481 ADS at about $52

Q: What insider transactions did GSK (GSK) disclose in this report?

GSK disclosed that President Maya Martinez-Davis sold GSK American Depositary Shares on 20 August 2026 and 21 August 2026 on the New York Stock Exchange, in two separate transactions totaling 3,916 ADS and 40,481 ADS, respectively, at prices around $52.14 per ADS.

Q: How many GSK (GSK) ADS did Maya Martinez-Davis sell on 20 August 2026?

On 20 August 2026, Maya Martinez-Davis sold 3,916 GSK ADS. These were executed in two tranches: 3,895 ADS at $52.1400 and 21 ADS at $52.1450, with an aggregated price of $52.1400 per ADS.

Q: How many GSK (GSK) ADS did Maya Martinez-Davis sell on 21 August 2026?

On 21 August 2026, Maya Martinez-Davis sold 40,481 GSK ADS. These were sold at prices of $52.1400, $52.1450, $52.1500, and $52.1650 per ADS, with an aggregated price of $52.1437 per ADS.

Q: What financial instrument did the GSK (GSK) insider trade involve?

The transactions involved GSK American Depositary Shares (ADS), identified with ISIN US37733W2044. These ADS represent an interest in GSK’s ordinary shares for trading in the U.S. market.

Q: Who is the insider named in GSK’s (GSK) August 2026 transaction notification?

The insider is Maya Martinez-Davis, identified as President and a person discharging managerial responsibilities (PDMR) at GSK plc. The notification is marked as an initial notification.

GSK plc (GSK) reports transactions by President Maya Martinez-Davis in the company’s American Depositary Shares (ADS).

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

GSK plc (GSK) reports transactions by President Maya Martinez-Davis in the company’s American Depositary Shares (ADS). On 20 August 2026, she sold 3,916 ADS on the New York Stock Exchange at an aggregated price of $52.1400 per ADS. On 21 August 2026, she sold a further 40,481 ADS at an aggregated price of $52.1437 per ADS, also on the NYSE.

Key Figures

ADS sold on 2026-08-20: 3,916 ADS Aggregated price on 2026-08-20: $52.1400 per ADS ADS sold on 2026-08-21: 40,481 ADS +2 more

5 metrics

ADS sold on 2026-08-20 3,916 ADS Sale of GSK American Depositary Shares by President Maya Martinez-Davis

Aggregated price on 2026-08-20 $52.1400 per ADS Average sale price for 3,916 ADS

ADS sold on 2026-08-21 40,481 ADS Sale of GSK American Depositary Shares by President Maya Martinez-Davis

Aggregated price on 2026-08-21 $52.1437 per ADS Average sale price for 40,481 ADS

Sale price tranches 2026-08-21 $52.1400, $52.1450, $52.1500, $52.1650 Individual execution prices for 40,481 ADS sold

Key Terms

American Depositary Shares, ISIN, Legal Entity Identifier, aggregated volume

4 terms

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

ISIN financial

"American Depositary Shares ('ADS') ISIN: US37733W2044"

A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.

Legal Entity Identifier financial

"LEI | 5493000HZTVUYLO1D793"

A legal entity identifier (LEI) is a unique, standardized code that functions like a global ID card for businesses and organizations involved in financial markets. It helps investors and regulators reliably identify who is on the other side of a deal, trace ownership and links between firms, and reduce confusion or fraud — improving transparency for reporting, risk assessment, and cross-border trades.

aggregated volume financial

"Aggregated information | Aggregated volume Price | 40,481 $52.1437"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GSK (GSK) disclose in this report?

GSK disclosed that President Maya Martinez-Davis sold GSK American Depositary Shares on 20 August 2026 and 21 August 2026 on the New York Stock Exchange, in two separate transactions totaling 3,916 ADS and 40,481 ADS, respectively, at prices around $52.14 per ADS.

How many GSK (GSK) ADS did Maya Martinez-Davis sell on 20 August 2026?

On 20 August 2026, Maya Martinez-Davis sold 3,916 GSK ADS. These were executed in two tranches: 3,895 ADS at $52.1400 and 21 ADS at $52.1450, with an aggregated price of $52.1400 per ADS.

How many GSK (GSK) ADS did Maya Martinez-Davis sell on 21 August 2026?

On 21 August 2026, Maya Martinez-Davis sold 40,481 GSK ADS. These were sold at prices of $52.1400, $52.1450, $52.1500, and $52.1650 per ADS, with an aggregated price of $52.1437 per ADS.

On which exchange were the GSK (GSK) ADS transactions executed?

Both sets of transactions by Maya Martinez-Davis in GSK American Depositary Shares were executed on the New York Stock Exchange (XNYS), according to the disclosure.

What financial instrument did the GSK (GSK) insider trade involve?

The transactions involved GSK American Depositary Shares (ADS), identified with ISIN US37733W2044. These ADS represent an interest in GSK’s ordinary shares for trading in the U.S. market.

Who is the insider named in GSK’s (GSK) August 2026 transaction notification?

The insider is Maya Martinez-Davis, identified as President and a person discharging managerial responsibilities (PDMR) at GSK plc. The notification is marked as an initial notification.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/24/2026 - 10:35 AM EDT Accepted by SEC EDGAR 08/24/2026 - 10:35 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Sale of 3,916 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$52.1400	3,895
			$52.1450	21

d)	Aggregated information
	Aggregated volume Price	3,916 $52.1400
e)	Date of the transaction	2026-08-20
f)	Place of the transaction	New York Stock Exchange (XNYS)

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Sale of 40,481 ADS
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$52.1400	11,154
			$52.1450	28,978
			$52.1500	300
			$52.1650	49

d)	Aggregated information
d)	Aggregated volume Price	40,481 $52.1437
e)	Date of the transaction	2026-08-21
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

	GSK plc
	(Registrant)

Date: August 24, 2026

	By:/s/ VICTORIA WHYTE --------------------------

	Victoria Whyte
	Authorised Signatory for and on
	behalf of GSK plc

Source: View Original Filing on SEC EDGAR